{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:54:30Z","timestamp":1790790870589,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1097\/cad.0b013e32831961b3","type":"journal-article","created":{"date-parts":[[2008,11,18]],"date-time":"2008-11-18T03:18:29Z","timestamp":1226978309000},"page":"1-6","source":"Crossref","is-referenced-by-count":51,"title":["Hypersensitivity reactions to antineoplastic agents: an overview"],"prefix":"10.1097","volume":"20","author":[{"given":"Ekaterini","family":"Syrigou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nektaria","family":"Makrilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Koti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad W.","family":"Saif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas N.","family":"Syrigos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210203","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1067\/mai.2003.93","article-title":"Drug allergy","volume":"111","author":"Gruchalla","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"R2-1-20210203","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1385\/CRIAI:24:3:253","article-title":"Hypersensitivity reactions to chemotherapeutic drugs","volume":"24","author":"Shepherd","year":"2003","journal-title":"Clin Rev Allergy Immunol"},{"key":"R3-1-20210203","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1634\/theoncologist.12-5-601","article-title":"Management and preparedness for infusion and hypersensitivity reactions","volume":"12","author":"Josef Lenz","year":"2007","journal-title":"Oncologist"},{"key":"R4-1-20210203","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/1097-0142(19920701)70:1<201::AID-CNCR2820700131>3.0.CO;2-M","article-title":"Allergic reactions to Erwinia asparaginase in children with acute lymphoblastic leukaemia who had previous allergic reactions to Escherichia coli asparaginase","volume":"70","author":"Billett","year":"1992","journal-title":"Cancer"},{"key":"R5-1-20210203","first-page":"161","article-title":"Hypersensitivity reactions to chemotherapy drugs","volume":"15","author":"Gonzalez","year":"2000","journal-title":"Alergol Immunol Clin"},{"key":"R6-1-20210203","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/sj.leu.2401162","article-title":"Anti-asparaginase antibodies following E. coli asparaginase therapy in pediatric acute lymphoblastic leukemia","volume":"12","author":"Woo","year":"1998","journal-title":"Leukemia"},{"key":"R7-1-20210203","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/1097-0142(197002)25:2<279::AID-CNCR2820250205>3.0.CO;2-7","article-title":"Chemical results of treatment with E coli L-asparaginase in adults with leukemia, lymphoma and solid tumors","volume":"25","author":"Clarkson","year":"1970","journal-title":"Cancer"},{"key":"R8-1-20210203","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0091-6749(98)70262-3","article-title":"Hypersensitivity reactions to Escherichia coli-derived polyethylene glycolated-asparaginase associated with subsequent immediate skin test reactivity to E. coli-derived granulocyte colony-stimulating factor","volume":"101","author":"Stone","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"R9-1-20210203","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/106002809703100517","article-title":"Paspargase: an alternative","volume":"31","author":"Holle","year":"1997","journal-title":"Ann Pharmacother"},{"key":"R10-1-20210203","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1002\/1097-0142(19910215)67:4<1070::AID-CNCR2820670434>3.0.CO;2-X","article-title":"Hypersensitivity reactions to epipodophyllotoxines in children with acute lymhoblastic leukemia","volume":"67","author":"Kellie","year":"1991","journal-title":"Cancer"},{"key":"R11-1-20210203","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1200\/JCO.1993.11.6.1080","article-title":"Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease","volume":"11","author":"Hudson","year":"1993","journal-title":"J Clin Oncol"},{"key":"R12-1-20210203","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1592\/phco.19.11.989.31566","article-title":"Successful rechallenge with etoposide phosphate after an acute hypersensitivity reaction to etoposide","volume":"19","author":"Bernstein","year":"1999","journal-title":"Pharmacotherapy"},{"key":"R13-1-20210203","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.bjc.6601303","article-title":"Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens","volume":"90","author":"Kloover","year":"2004","journal-title":"Br J Cancer"},{"key":"R14-1-20210203","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00404-004-0643-9","article-title":"Erythema multiforme major following docetaxel","volume":"271","author":"Moisidis","year":"2005","journal-title":"Arch Gynecol Obstet"},{"key":"R15-1-20210203","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1358\/dot.2006.42.9.1009902","article-title":"Nanoparticle albumine-bound paclitaxel for treatment of metastatic breast cancer","volume":"42","author":"Pinder","year":"2006","journal-title":"Drugs Today (Barc)"},{"key":"R16-1-20210203","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ygyno.2005.08.004","article-title":"Cross-sensitivity between paclitaxel and docetaxel in a women's cancers program","volume":"100","author":"Dizon","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R17-1-20210203","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0090-8258(03)00155-0","article-title":"Relationship between a history of systemic allergic reaction and risk of subsequent carboplatin hypersensitivity","volume":"89","author":"Markman","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R18-1-20210203","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3816\/CCC.2006.n.027","article-title":"Oxaliplatin-associated hypersensitivity reactions: clinical presentation and management","volume":"6","author":"Hewitt","year":"2006","journal-title":"Clin Colorectal Cancer"},{"key":"R19-1-20210203","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jaci.2006.11.640","article-title":"Diagnostic and predictive value of skin testing in platinum salt hypersensitivity","volume":"119","author":"Leguy-Seguin","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"R20-1-20210203","doi-asserted-by":"crossref","first-page":"199.e1","DOI":"10.1016\/j.ajog.2007.04.044","article-title":"Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer","volume":"197","author":"Callahan","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R21-1-20210203","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/01.pap.0000249924.90645.5b","article-title":"Oxaliplatin hypersensitivity: case report and successful repeat desensitization","volume":"14","author":"Edmondson","year":"2007","journal-title":"Am J Ther"},{"key":"R22-1-20210203","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1345\/aph.1E532","article-title":"Successful desensitization to oxaliplatin","volume":"39","author":"Mis","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R23-1-20210203","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1634\/theoncologist.9-5-546","article-title":"Hypersensitivity reactions to oxaliplatin and the application of a desensitization protocol","volume":"9","author":"Gammon","year":"2004","journal-title":"Oncologist"},{"key":"R24-1-20210203","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1097\/01.cad.0000132235.38297.7c","article-title":"Hypersensitivity reactions to oxaliplatin: a case report and the success of a continuous infusional desensitization schedule","volume":"15","author":"Lim","year":"2004","journal-title":"Anticancer Drugs"},{"key":"R25-1-20210203","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2165\/00003495-199700544-00007","article-title":"Safety aspects of pegylated liposomal doxorubicin in patients with cancer","volume":"54","author":"Alberts","year":"1997","journal-title":"Drugs"},{"key":"R26-1-20210203","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/annonc\/mdg374","article-title":"Complement activation following first exposure to pegylated doxorubicin (Doxil): possible role on hypersensitivity reactions","volume":"14","author":"Chanan-Khan","year":"2003","journal-title":"Ann Oncol"},{"key":"R27-1-20210203","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00001813-199801000-00005","article-title":"Mechanism of transient dyspnea induced by pegylated-liposomal doxorubicin (Doxil)","volume":"9","author":"Skubitz","year":"1998","journal-title":"Anti-Cancer Drugs"},{"key":"R28-1-20210203","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1002\/1097-0142(19920515)69:10<2532::AID-CNCR2820691024>3.0.CO;2-I","article-title":"Hypersensitivity reactions to procarbazine with mechlorethamine vincristine and procarbazine chemotherapy in treatment of glioma","volume":"69","author":"Coyle","year":"1992","journal-title":"Cancer"},{"key":"R29-1-20210203","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ajh.2830320314","article-title":"Allergic reaction with immune haemolytic anemia resulting from chlorambucil","volume":"32","author":"Thompson-Moya","year":"1989","journal-title":"Am J Hematol"},{"key":"R30-1-20210203","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1080\/10428190500085107","article-title":"Allergic reaction to chlorambucil in chronic lympholytic leykemia presenting with fever and lymphadenopathy","volume":"46","author":"Levin","year":"2005","journal-title":"Leuk Lymphoma"},{"key":"R31-1-20210203","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0091-6749(96)70279-8","article-title":"Allergic reactions to cyclophosphamide: delayed clinical expression associated with positive immediate skin tests to drug metabolites in five patients","volume":"97","author":"Popescu","year":"1996","journal-title":"J Allergy Clin Immunol"},{"key":"R32-1-20210203","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1345\/aph.1G235","article-title":"The need for routine Bleomycin test dosing in the 21st century","volume":"39","author":"Lam","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R33-1-20210203","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/1097-0142(19950101)75:1<110::AID-CNCR2820750118>3.0.CO;2-I","article-title":"Acute basophilic leukemia in a child. Anaphylactoid reaction and coagulopathy secondary to vincristine-mediated degranulation","volume":"75","author":"Bernini","year":"1995","journal-title":"Cancer"},{"key":"R34-1-20210203","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1572-0241.2003.07413.x","article-title":"Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine","volume":"98","author":"Dubinski","year":"2003","journal-title":"Am J Gastrenterol"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e32831961b3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:30:21Z","timestamp":1786037421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200901000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e32831961b3","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}